Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Trop Med Int Health. 2010 May 7;15(7):842–847. doi: 10.1111/j.1365-3156.2010.02540.x

Figure 1.

Figure 1

Cohort profile of HIV-infected women with known nevirapine exposure status starting initiating non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy from April 2004 to July 2006 enrolled for at least 12 months

* Source population represents the cohort for our previous analysis of early clinical outcomes